Theravance Inc. (THRX) Reports In-Line Q1 EPS

Theravance Inc. (NASDAQ: THRX) reported Q1 EPS of ($0.28), in-line with the analyst estimate of ($0.28). Revenue for the quarter came in at $6.3 million versus the consensus estimate of $6.52 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
• Metalla Royalty & Streaming Ltd. (MTA) Reports In-Line Q2 EPS